ID

39918

Description

Nebivolol in Patients With Systolic Stage 2 Hypertension; ODM derived from: https://clinicaltrials.gov/show/NCT01057251

Link

https://clinicaltrials.gov/show/NCT01057251

Keywords

Versions (1)
  1. 3/4/20 3/4/20 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

March 4, 2020

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Hypertension NCT01057251

English

Eligibility Hypertension NCT01057251

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
male of female, 18 to 64 years of age at screening
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
mean seated heart rate at least 60 bpm
Description

Heart rate while sitting mean

Data type

boolean

Alias
UMLS CUI [1,1]
C2029904
UMLS CUI [1,2]
C0444504
diagnosed systolic stage 2 hypertension
Description

Systolic hypertension Stage

Data type

boolean

Alias
UMLS CUI [1,1]
C0221155
UMLS CUI [1,2]
C0699749
unremarkable physical exam findings
Description

Findings Normal Physical Examination

Data type

boolean

Alias
UMLS CUI [1,1]
C0037088
UMLS CUI [1,2]
C0205307
UMLS CUI [1,3]
C0031809
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
high risk due to secondary hypertension or former stage 3 hypertension by jnc6
Description

High risk | Secondary hypertension | Hypertensive disease Previous Stage

Data type

boolean

Alias
UMLS CUI [1]
C4319571
UMLS CUI [2]
C0155616
UMLS CUI [3,1]
C0020538
UMLS CUI [3,2]
C0205156
UMLS CUI [3,3]
C0699749
concurrent conditions (reno, cardiovascular, obesity, thyroid, etc)
Description

Comorbidity | Kidney Diseases | Cardiovascular Diseases | Obesity | Thyroid Diseases

Data type

boolean

Alias
UMLS CUI [1]
C0009488
UMLS CUI [2]
C0022658
UMLS CUI [3]
C0007222
UMLS CUI [4]
C0028754
UMLS CUI [5]
C0040128
currently taking medication that cannot be stopped during the course of the study
Description

Pharmaceutical Preparation Discontinue Unsuccessful

Data type

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C1444662
UMLS CUI [1,3]
C1272705
participating other clinical trials
Description

Study Subject Participation Status | Clinical Trial

Data type

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2]
C0008976
member of the study center personnel
Description

Member Research Personnel

Data type

boolean

Alias
UMLS CUI [1,1]
C0680022
UMLS CUI [1,2]
C0035173
documented drug abuse
Description

Drug abuse

Data type

boolean

Alias
UMLS CUI [1]
C0013146
contra indication to beta blocker
Description

Medical contraindication Adrenergic beta-1 Receptor Antagonists

Data type

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C0304516
abnormal lab finding
Description

Laboratory test result abnormal

Data type

boolean

Alias
UMLS CUI [1]
C0438215
poor compliance
Description

Poor compliance

Data type

boolean

Alias
UMLS CUI [1]
C0032646
other conditions judged by investigator that is not suitable for the study
Description

Condition Inappropriate Clinical Trial

Data type

boolean

Alias
UMLS CUI [1,1]
C0348080
UMLS CUI [1,2]
C1548788
UMLS CUI [1,3]
C0008976
Back to the top of the page

Similar models

Eligibility Hypertension NCT01057251

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
male of female, 18 to 64 years of age at screening
boolean
C0001779 (UMLS CUI [1])
Heart rate while sitting mean
Item
mean seated heart rate at least 60 bpm
boolean
C2029904 (UMLS CUI [1,1])
C0444504 (UMLS CUI [1,2])
Systolic hypertension Stage
Item
diagnosed systolic stage 2 hypertension
boolean
C0221155 (UMLS CUI [1,1])
C0699749 (UMLS CUI [1,2])
Findings Normal Physical Examination
Item
unremarkable physical exam findings
boolean
C0037088 (UMLS CUI [1,1])
C0205307 (UMLS CUI [1,2])
C0031809 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
High risk | Secondary hypertension | Hypertensive disease Previous Stage
Item
high risk due to secondary hypertension or former stage 3 hypertension by jnc6
boolean
C4319571 (UMLS CUI [1])
C0155616 (UMLS CUI [2])
C0020538 (UMLS CUI [3,1])
C0205156 (UMLS CUI [3,2])
C0699749 (UMLS CUI [3,3])
Comorbidity | Kidney Diseases | Cardiovascular Diseases | Obesity | Thyroid Diseases
Item
concurrent conditions (reno, cardiovascular, obesity, thyroid, etc)
boolean
C0009488 (UMLS CUI [1])
C0022658 (UMLS CUI [2])
C0007222 (UMLS CUI [3])
C0028754 (UMLS CUI [4])
C0040128 (UMLS CUI [5])
Pharmaceutical Preparation Discontinue Unsuccessful
Item
currently taking medication that cannot be stopped during the course of the study
boolean
C0013227 (UMLS CUI [1,1])
C1444662 (UMLS CUI [1,2])
C1272705 (UMLS CUI [1,3])
Study Subject Participation Status | Clinical Trial
Item
participating other clinical trials
boolean
C2348568 (UMLS CUI [1])
C0008976 (UMLS CUI [2])
Member Research Personnel
Item
member of the study center personnel
boolean
C0680022 (UMLS CUI [1,1])
C0035173 (UMLS CUI [1,2])
Drug abuse
Item
documented drug abuse
boolean
C0013146 (UMLS CUI [1])
Medical contraindication Adrenergic beta-1 Receptor Antagonists
Item
contra indication to beta blocker
boolean
C1301624 (UMLS CUI [1,1])
C0304516 (UMLS CUI [1,2])
Laboratory test result abnormal
Item
abnormal lab finding
boolean
C0438215 (UMLS CUI [1])
Poor compliance
Item
poor compliance
boolean
C0032646 (UMLS CUI [1])
Condition Inappropriate Clinical Trial
Item
other conditions judged by investigator that is not suitable for the study
boolean
C0348080 (UMLS CUI [1,1])
C1548788 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial